Memantine Sandoz

Memantine, the active ingredient in Memantine Sandoz, is a NMDA receptor antagonist presented as a tablet for oral use. It is used to treat cognitive symptoms of Alzheimer’s disease in adults. GNH USA supplies Memantine Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine acts on the glutamatergic pathway and is indicated for the treatment of Alzheimer’s disease. Alzheimer's disease: helps improve cognition and functional abilities in patients with mild to moderate disease.

Memantine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Headache: mild to moderate pain in the head region. - Constipation: reduced bowel movements or hard stools. - Confusion: transient disorientation or difficulty concentrating. - Hypertension: elevated blood pressure readings. - Somnolence: increased sleepiness or fatigue.

Serious or Rare Side Effects: - Seizures: convulsive episodes requiring immediate medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hallucinations: visual or auditory disturbances. - Cardiac arrhythmia: irregular heart rhythm. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures. Renal impairment: adjust dose or monitor renal function. Hepatic impairment: use with caution in patients with liver disease. Concomitant NMDA antagonists: avoid combined use to reduce risk of additive CNS effects. History of seizures: monitor closely for increased seizure activity. Pregnancy and lactation: safety not established; weigh benefits against potential risks. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Memantine may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism can increase neuropsychiatric side effects. - Cimetidine: may raise memantine plasma concentrations, enhancing toxicity.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): may augment dizziness or somnolence. - Anticholinergic agents: could diminish therapeutic benefit on cognition. - Antihypertensive drugs: monitor blood pressure for additive hypotensive effects.